MoneyWorks4Me

Senores Pharmaceutic - Quaterly Results

23 Jan 2025 Evaluate
The revenue zoomed 7.63% to Rs. 95.90 millions for the quarter ended December 2024 as compared to Rs. 89.10 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 435.00% to Rs. 10.70  millions  from Rs. 2.00 millions in previous same quarter.Operating profit for the quarter ended December 2024 rose to 47.70 millions as compared to 16.20 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202412 202312 % Var
Sales 95.90 89.10 7.63 95.90 89.10 7.63 95.90 89.10 7.63
Other Income 71.90 21.50 234.42 71.90 21.50 234.42 71.90 21.50 234.42
PBIDT 47.70 16.20 194.44 47.70 16.20 194.44 47.70 16.20 194.44
Interest 27.00 6.70 302.99 27.00 6.70 302.99 27.00 6.70 302.99
PBDT 20.70 9.50 117.89 20.70 9.50 117.89 20.70 9.50 117.89
Depreciation 7.50 4.60 63.04 7.50 4.60 63.04 7.50 4.60 63.04
PBT 13.20 4.90 169.39 13.20 4.90 169.39 13.20 4.90 169.39
TAX 2.50 2.90 -13.79 2.50 2.90 -13.79 2.50 2.90 -13.79
Deferred Tax -0.30 0.20 -250.00 -0.30 0.20 -250.00 -0.30 0.20 -250.00
PAT 10.70 2.00 435.00 10.70 2.00 435.00 10.70 2.00 435.00
Equity 460.50 299.50 53.76 460.50 299.50 53.76 460.50 299.50 53.76
PBIDTM(%) 49.74 18.18 173.57 49.74 18.18 173.57 49.74 18.18 173.57
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..